share_log

The Analyst Landscape: 7 Takes On TScan Therapeutics

アナリストの風景:TScan Therapeuticsに関する7つの意見

Benzinga ·  06/04 11:01

Analysts' ratings for TScan Therapeutics (NASDAQ:TCRX) over the last quarter vary from bullish to bearish, as provided by 7 analysts.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings52000
Last 30D10000
1M Ago30000
2M Ago01000
3M Ago11000

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $12.43, with a high estimate of $15.00 and a low estimate of $9.00. This upward trend is evident, with the current average reflecting a 0.81% increase from the previous average price target of $12.33.

price target chart

Interpreting Analyst Ratings: A Closer Look

The analysis of recent analyst actions sheds...

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする